MBP-426
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MBP-426, covering 2014-12-02 to 2014-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors [Phase 1]